Superworth

Biomerica EV/EBIT BMRA

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2012.

Today, Oct 23, 2026
n/m
an operating loss
Last meaningful
136×
Jan 2014
Peer median
8.2×

Biomerica has no meaningful EV/EBIT today: it made an operating loss of $5.4M over the last twelve months.

It was last meaningful in Jan 2014, at 136×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2014136×128×136×
2013130×6.4×172×
20126.5×6.1×9.6×

Against its peers

Companies in Healthcare nearest Biomerica's size, closest first, today.

CompanyEV/EBIT
BMRABiomerican/m
NEPHNephros20.5×
ATNMActinium Pharmaceuticals1.2×
APTAlpha Pro Tech8.2×
SPROSpero Therapeutics2.1×
LFVNLifevantage9.6×
Peer median8.2×

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Biomerica

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.